In addition, the study also identifies that GRHL2 mediated activation of MAP kinase signaling and repression of TGF-β signaling in oral squamous cell carcinoma cell lines, dually render tumor promoting effects during the early stages of carcinogenesis. Here, GRHL2 is linked to oral cavity squamous cell carcinoma.